Compare FTAI Aviation Ltd (FTAI) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FTAI Aviation Ltd vs Oruka Therapeutics Inc. Common Stock — how do they compare? FTAI Aviation Ltd trades at $156.8 (market cap $16.75B), while Oruka Therapeutics Inc. Common Stock trades at $77.2 (market cap $5.08B). The key difference: FTAI Aviation Ltd is far larger — about 3.3× Oruka Therapeutics Inc. Common Stock's market cap, and FTAI Aviation Ltd pays a 1.23% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold FTAI Aviation Ltd for 24 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| FTAI | ORKA | |
|---|---|---|
Market Cap | $16.75B | $5.08B |
Volume | 2,940,634 | 685,276 |
Sector | Industrials | Health |
52-Week High | $310.04 | $113.08 |
52-Week Low | $152.80 | $26.19 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $19.87B | $4.21B |
Dividend Yield | 1.23% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FTAI Aviation trades at $166.87, showing modest daily gains of 0.81% but facing bearish technical signals with 16 sell indicators versus 3 buy signals. The company reported strong revenue growth to $2.51 billion in 2025 with a 19.98% net profit margin, though recent quarters show earnings misses against expectations. Recent developments include a $500 million share repurchase program and acquisition of 27 Boeing 737-700 aircraft, signaling strategic expansion in aerospace services.
Despite technical weakness, FTAI maintains unanimous analyst buy ratings with a $321.25 consensus target representing 92% upside potential. Key risks include consecutive earnings misses and negative operating cash flow, while catalysts include the buyback program and aerospace sector growth. The stock presents a compelling value opportunity if operational execution improves to match analyst optimism.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About FTAI Aviation Ltd
FTAI Aviation owns and maintains a fleet of commercial aircraft and engines. It focuses on the specialized maintenance of the CFM56 engine, helping airlines reduce costs through efficient asset management.
Read more on FTAI →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
